Deutsches Zentrum für Kinder- und Jugendrheumatologie
Garmisch Partenkirchen, Germany
Medical center in Garmisch-Partenkirchen, Bavaria
Gehfeldstraße 24, 82467 Garmisch-Partenkirchen
About Deutsches Zentrum für Kinder- und Jugendrheumatologie
The German Center for Pediatric and Adolescent Rheumatology in Garmisch-Partenkirchen is the largest specialized center for the treatment of children and adolescents with rheumatic diseases and chronic pain syndromes in Europe.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
St. Franziskus Hospital
1
Clinical Trials at Deutsches Zentrum für Kinder- und Jugendrheumatologie
During the past decade, Deutsches Zentrum für Kinder- und Jugendrheumatologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cyclosporine A in the Treatment of Juvenile Idiopathic Arthritis (JIA) Associated Chronic Anterior Uveitis
1991-01-01
2006-08-01
Completed
60
Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis
2013-03-18
2025-11-08
Recruiting
340
A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA
2018-05-10
2024-03-26
Recruiting
100
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Deutsches Zentrum für Kinder- und Jugendrheumatologie
According to Clinical.Site data, the most researched conditions in "Deutsches Zentrum für Kinder- und Jugendrheumatologie" are
"Juvenile Idiopathic Arthritis" (2 trials), "Arthritis Juvenile Idiopathic" (1 trials) and "Uveitis" (1 trials). Many other conditions were trialed in "Deutsches Zentrum für Kinder- und Jugendrheumatologie" in a lesser frequency.
Clinical Trials Intervention Types at Deutsches Zentrum für Kinder- und Jugendrheumatologie
Most popular intervention types in "Deutsches Zentrum für Kinder- und Jugendrheumatologie" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Cyclosporine A" (1 trials), "In double-blind phase: treatment with tofacitinib or placebo in 1:1 ratio" (1 trials), "In open-label phase: treatment with tofacitinib" (1 trials) and "Tofacitinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Deutsches Zentrum für Kinder- und Jugendrheumatologie
The vast majority of trials in "Deutsches Zentrum für Kinder- und Jugendrheumatologie" are
3 trials for "All" genders.
Clinical Trials Status at Deutsches Zentrum für Kinder- und Jugendrheumatologie
Currently, there are NaN active trials in "Deutsches Zentrum für Kinder- und Jugendrheumatologie".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Deutsches Zentrum für Kinder- und Jugendrheumatologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Deutsches Zentrum für Kinder- und Jugendrheumatologie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".